このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Comparative Evaluation of Contrast-Enhanced MRI and FDG-PET/CT in Spinal Pathology: Image Quality and Short-Term Renal-Hematologic Safety

2026年6月5日 更新者:Ahmed Elgendi、Cairo University

This prospective comparative observational study evaluates image quality characteristics and short-term physiological effects associated with contrast-enhanced magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in patients with cervical and lumbar spinal pathologies.

A total of 120 adult participants undergo either contrast-enhanced MRI or FDG-PET/CT as part of routine clinical evaluation. Image quality is assessed using quantitative metrics, including signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR), as well as qualitative Visual Grading Analysis (VGA) performed by blinded radiologists. Short-term physiological effects are evaluated using blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and hemoglobin measurements obtained before imaging and 48 hours after imaging.

The study aims to compare image quality characteristics and short-term physiological parameters associated with these imaging modalities and to examine the influence of age group and spinal region on imaging performance.

調査の概要

詳細な説明

Background and Rationale

Magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) are widely used imaging modalities for the evaluation of cervical and lumbar spinal disorders. MRI primarily provides high-resolution anatomical information, whereas FDG-PET/CT provides metabolic and functional information that may assist in the assessment of inflammatory, infectious, degenerative, and neoplastic spinal conditions. Although both modalities are routinely used in clinical practice, differences in image quality characteristics and short-term physiological effects associated with imaging procedures remain areas of interest.

Study Design

This study is a prospective comparative observational study designed to evaluate image quality characteristics and short-term physiological effects associated with contrast-enhanced MRI and FDG-PET/CT in adult patients with cervical or lumbar spinal pathologies. A total of 120 participants are included, with 60 participants undergoing contrast-enhanced MRI and 60 participants undergoing FDG-PET/CT according to routine clinical indications and standard institutional workflows.

The study is non-interventional. No experimental treatments, investigational drugs, or deviations from standard clinical care are introduced. All imaging procedures are performed according to established institutional protocols and manufacturer recommendations.

Study Population

Eligible participants are adults with clinically suspected or confirmed cervical or lumbar spinal pathology requiring advanced imaging evaluation. Conditions may include degenerative, inflammatory, infectious, neoplastic, traumatic, or post-surgical spinal disorders.

Imaging Procedures

MRI examinations are performed using a 3 Tesla scanner equipped with a dedicated spinal coil. Standard spinal imaging protocols include sagittal and axial T1-weighted and T2-weighted sequences. Intravenous gadolinium-based contrast administration is performed according to institutional guidelines and standard clinical practice.

FDG-PET/CT examinations are performed following standard patient preparation procedures, including fasting requirements and blood glucose assessment. Intravenous administration of 18F-fluorodeoxyglucose (FDG) is followed by image acquisition using routine clinical PET/CT protocols. CT acquisition is used for attenuation correction and anatomical localization according to institutional practice.

Image Quality Assessment

Quantitative image quality assessment includes measurement of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) using standardized regions of interest. Measurements are performed using predefined image analysis procedures to ensure consistency across participants.

Qualitative image quality assessment is performed using Visual Grading Analysis (VGA). Independent blinded radiologists evaluate image quality using predefined criteria related to anatomical detail, tissue contrast, lesion conspicuity, image noise, and overall diagnostic usability.

Physiological and Safety Assessments

Short-term physiological effects associated with imaging procedures are evaluated using laboratory measurements obtained before imaging and 48 hours after imaging. Laboratory assessments include blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and hemoglobin concentration.

Routine safety monitoring is performed according to institutional standards. Adverse events associated with contrast administration or imaging procedures are documented and managed according to standard clinical protocols.

Subgroup Analyses

Prespecified subgroup analyses evaluate image quality metrics according to spinal region (cervical versus lumbar) and age group (50 years or younger versus older than 50 years). These analyses are intended to explore potential differences in imaging performance across clinically relevant patient subgroups.

Study Objectives

The primary objectives are to compare quantitative image quality metrics between contrast-enhanced MRI and FDG-PET/CT and to evaluate qualitative image quality using blinded radiologist assessment.

Secondary objectives include assessment of short-term changes in renal and hematologic laboratory parameters following imaging procedures performed as part of routine clinical care.

Ethics

The study is conducted in accordance with applicable ethical principles, institutional policies, and approved research protocols. Institutional Review Board approval has been obtained, and informed consent procedures are implemented as required by the approved protocol and applicable regulations.

研究の種類

観察的

入学 (実際)

120

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Giza Governorate
      • Giza、Giza Governorate、エジプト、43556
        • (MISR University Scientific Research Innovation Committee,

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

サンプリング方法

非確率サンプル

調査対象母集団

Participants will be recruited from the general population through community outreach, advertisements, and screening visits. Individuals who meet the eligibility criteria will be invited to participate.

説明

Inclusion Criteria:

  • Age 18 years or older.
  • Clinically suspected or confirmed cervical or lumbar spinal pathology.
  • Presence of symptoms suggestive of spinal disease, including radiculopathy, localized spinal pain, neurological deficits, or suspected metastatic involvement.
  • Referred for diagnostic evaluation with contrast-enhanced MRI or FDG-PET/CT according to routine clinical indications.
  • Availability of baseline clinical and laboratory data, including renal function assessment.
  • Ability to provide informed consent.

Exclusion Criteria:

  • Severe renal impairment (eGFR <30 mL/min/1.73 m²) or acute kidney injury.
  • Known hypersensitivity to gadolinium-based contrast agents or 18F-FDG.
  • Contraindications to MRI, including non-compatible metallic implants or severe claustrophobia.
  • Pregnancy or breastfeeding.
  • Uncontrolled diabetes mellitus (blood glucose >200 mg/dL at the time of PET/CT examination).
  • Active systemic infection or inflammatory condition requiring immediate treatment.
  • Inability to complete the required imaging procedures.
  • Incomplete clinical, laboratory, or imaging data required for study evaluation.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
patient allocation to MRI (n=60) and FDG-PET/CT (n=60) groups with stratification by spinal re-gion

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Quantitative Image Quality Assessment
時間枠:Assessed at the imaging visit (up to 1 day).

Secondary Outcome Measure 1

Outcome Measure:

Blood Urea Nitrogen (BUN)

Description:

Change in serum blood urea nitrogen concentration following imaging procedures.

Time Frame:

Baseline (pre-imaging) and 48 hours post-imaging.

Unit of Measure:

mg/dL

Secondary Outcome Measure 2

Outcome Measure:

Estimated Glomerular Filtration Rate (eGFR)

Description:

Change in estimated glomerular filtration rate following imaging procedures.

Time Frame:

Baseline (pre-imaging) and 48 hours post-imaging.

Unit of Measure:

mL/min/1.73 m²

Secondary Outcome Measure 3

Outcome Measure:

Hemoglobin Level

Description:

Change in hemoglobin concentration following imaging procedures.

Time Frame:

Baseline (pre-imaging) and 48 hours post-imaging.

Unit of Measure:

g/dL

Secondary Outcome Measure 4

Outcome Measure:

Visual Grading Analysis (VGA) Score

Description:

Qualitative image quality assessment performed by blinded radiologists to evaluate anatomical clarity, lesion delineation, image contrast, and

Assessed at the imaging visit (up to 1 day).

二次結果の測定

結果測定
メジャーの説明
時間枠
Comparative Evaluation of Image Quality and Short-Term Physiological Effects of Contrast-Enhanced MRI versus FDG-PET/CT in Cervical and Lumbar Spine Pathologies
時間枠:For image quality assessment: At the time of imaging For short-term physiological effects (BUN, eGFR, hemoglobin): Baseline (pre-imaging) and 48 hours post-imaging

Short-term physiological effects of contrast-enhanced MRI and FDG-PET/CT, assessed via changes in renal function and hematologic parameters:

Serum blood urea nitrogen (BUN) at baseline and 48 hours post-imaging Estimated glomerular filtration rate (eGFR) at baseline and 48 hours post-imaging Hemoglobin levels at baseline and 48 hours post-imaging Qualitative image evaluation, measured by Visual Grading Analysis (VGA) performed by blinded radiologists to assess anatomical clarity, lesion delineation, and overall diagnostic usability.

For image quality assessment: At the time of imaging For short-term physiological effects (BUN, eGFR, hemoglobin): Baseline (pre-imaging) and 48 hours post-imaging

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

  • References 1. Altman, D.G. Practical Statistics for Medical Research (1st ed.); Chapman and Hall/CRC, 1990. 2. Andreucci, M.; Solomon, R.; Tasanarong, A. Side effects of radiographic contrast media: pathogenesis, risk factors, and pre-vention. Biomed Res Int. 2014, 2014, 741018. 3. Association, W.M. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama 2013, 310, 2191-4. 4. Bajwa, H.; Sritharan, T.; Botha, T.; et al. Assessment of cervical spine CT by an image quality audit using qualitative and quantitative methods. J Med Imaging Radiat Oncol. 2025, 69, 7-16. 5. Benchoufi, M.; Matzner-Lober, E.; Molinari, N.; et al. Interobserver agreement issues in radiology. Diagn Interv Imaging 2020, 101, 639-41. 6. Beyer, T.; Bailey, D.L.; Birk, U.J.; et al. Medical Physics and Imaging-A Timely Perspective. Front. Phys. 2021, 9, 634693. 7. Boellaard, R.; Delgado-Bolton, R.; Oyen, W.J.; et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015, 42, 328-54. 8. Boos, N.; Rieder, R.; Schade, V.; et al. The Imaging characteristics of Magnetic Resonance Imaging, Work Perception, and Psychosocial Factors in Identifying Symptomatic Disc Herniations. Spine 1995, 20. 9. Boriani, L.; Zamparini, E.; Albrizio, M.; et al. Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline. Curr Med Imaging 2022, 18, 216-30. 10. Brinjikji, W.; Luetmer, P.H.; Comstock, B.; et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015, 36, 811-6. 11. Brown, T.F.; Yasillo, N.J. Radiation safety considerations for PET centers. J Nucl Med Technol. 1997, 25, 98-102; quiz 4-5. 12. Burmeister, H.P.; Baltzer, P.A.; Möslein, C.; et al. Visual grading characteristics (VGC) analysis of diagnostic image quality for high resolution 3 Tesla MRI vol

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年4月5日

一次修了 (実際)

2025年11月3日

研究の完了 (実際)

2026年1月1日

試験登録日

最初に提出

2026年5月31日

QC基準を満たした最初の提出物

2026年6月5日

最初の投稿 (実際)

2026年6月10日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月10日

QC基準を満たした最後の更新が送信されました

2026年6月5日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する